S. Nozawa et al., Characteristics of immunoglobulin gene usage of the xenoantibody binding to Gal-alpha(1,3)Gal target antigens in the Gal knockout mouse, TRANSPLANT, 72(1), 2001, pp. 147-155
Background Natural antibodies that react with galactose-alpha (1,3)galactos
e [gal alpha (1,3)gal] carbohydrate epitopes exist in humans and Old World
primates because of the inactivation of the alpha1,3-galactosyltransferase
(alpha1,3GT) gene in these species and the subsequent production of antibod
ies to environmental microbes that express the gal alpha (1,3)gal antigen.
The Gal knockout (Gal o/o) mouse, produced by homologous disruption of the
alpha1,3GT gene, spontaneously makes anti-gal alpha (1,3)gal antibodies and
can be used to study the genetic control of humoral immune responses to th
is carbohydrate epitope.
Methods. Six hybridomas that produce monoclonal antibodies (mAbs) to gal al
pha (1,3)gal were generated in Gal o/o mice. The mAbs were tested to charac
terize the binding activity with flow cytometry using pig aortic endothelia
l cells and ELISA with gal alpha (1,3)gal carbohydrates, The V-H and V-K ge
nes of these hybridomas were cloned, sequenced, and analyzed.
Results. The mAbs showed distinct patterns of antibody binding to gal alpha
(1,3)gal antigens, The V-H genes that encode the mAb binding activity were
restricted to a small number of genes expressed in their germline configur
ation. Four of six clones used closely related progeny of the same V-H germ
line gene (V(H)441). Comparison of the mouse gene V(H)441 to the human gene
IGWV3-11, a gene that encodes antibody activity to gal alpha (1,3)gal in h
umans, demonstrates that these two genes share a nonrandom distribution of
amino acids used at canonical binding sites within the variable regions (co
mplimentary determining regions 1 and 2) of their immunoglobulin V, genes.
Conclusions. These results demonstrate the similarity of the Gal o/o mice a
nd humans in their immune response to gal alpha (1,3)gal epitopes. Gal o/o
mouse can serve as a useful model for examining the genetic control of anti
body/antigen interactions associated with the humoral response to pig xenog
rafts in humans.